UFM
LBPS

Ursa Fund Management’s 4D Pharma PLC LBPS Stock Holding History

Ursa Fund Management’s Portfolio LBPS Stock Details LBPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-148,098
Closed -$1.75M – 23
2021
Q1 		$1.75M Buy
+148,098
New +$1.85M 1.9% 11

Other funds holding LBPS

RL
Ruffer LLP London, United Kingdom $2.44B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ursa Fund Management's LBPS Position: Q2 2021 in Review

Ursa Fund Management sold out of 4D Pharma PLC (LBPS) in Q2 2021, closing a stake of 148,098 shares — an estimated $1.75M sold.

Ursa Fund Management first reported a position in LBPS in Q1 2021 and held it in 1 quarter. The position peaked at $1.75M in Q1 2021. 4 funds tracked by Wall St. Rank hold LBPS as of Q2 2021.

  • Ursa Fund Management reported no remaining 4D Pharma PLC position as of Q2 2021 after selling out during the quarter.
  • Ursa Fund Management sold 148,098 4D Pharma PLC shares in Q2 2021, an estimated $1.75M.
  • Ursa Fund Management first reported a position in 4D Pharma PLC in Q1 2021 and held it in 1 quarter.
  • Ursa Fund Management's 4D Pharma PLC position peaked at $1.75M in Q1 2021.
  • 4 funds tracked by Wall St. Rank held 4D Pharma PLC as of Q2 2021.

Based on Ursa Fund Management's 13F filing for Q2 2021, filed 16 Aug 2021.